Can You Regain Weight After Stopping GLP-1? What Medical Research Shows

22 October 2026 | Reviewed by Dr. Ovin Endah Lestari,

GLP-1-based medications such as semaglutide have become increasingly recognized as treatment options for medical weight management in eligible patients with obesity or overweight.

Medications such as Wegovy (semaglutide) and Mounjaro (tirzepatide) can help regulate appetite, increase feelings of fullness, and support weight loss.

However, one of the most common concerns among patients is: Will I regain weight after stopping GLP-1 treatment?

The short answer is yes, weight regain can occur after stopping GLP-1-based medication. This is commonly referred to as weight regain.

Clinical studies have shown that some patients regain a significant proportion of their previously lost weight after discontinuing treatment.

However, the amount of weight regained varies between individuals. Long-term outcomes depend on biological responses, dietary habits, physical activity, metabolic health, and the weight maintenance strategy followed after treatment.

Why Does Weight Regain Happen After Stopping GLP-1?

To understand weight regain, it helps to understand how GLP-1-based medications work.

GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone involved in appetite regulation, satiety, and glucose metabolism.

GLP-1 receptor agonists such as semaglutide activate GLP-1 receptors, helping reduce hunger and increase feelings of fullness.

Tirzepatide, on the other hand, activates two hormone receptors: GIP and GLP-1.

During treatment, patients may find it easier to reduce their calorie intake because they feel less hungry and become satisfied with smaller portions.

When the medication is discontinued, these pharmacological effects gradually diminish.

Several changes may then contribute to weight regain.

1. Hunger May Increase Again

As the medication's effects wear off, appetite regulation may gradually return toward its pretreatment state.

Patients may begin feeling hungry more frequently or require larger portions to feel satisfied.

If energy intake consistently increases beyond the body's requirements, weight regain may occur.

2. The Body Has Biological Mechanisms That Resist Weight Loss

Following significant weight loss, the body may activate biological responses that encourage weight regain.

These responses can involve changes in appetite-regulating hormones, energy expenditure, and signals involved in energy balance.

As a result, maintaining a lower body weight can be more challenging than expected, even after successful treatment.

3. Calorie Requirements Change After Weight Loss

A person with a lower body weight generally requires less energy than when they were heavier.

If a patient returns to their previous eating habits, their calorie intake may exceed their new energy requirements.

Over time, this can contribute to weight regain.

4. Long-Term Lifestyle Habits May Not Yet Be Established

GLP-1-based medications can help control appetite, but they do not automatically establish sustainable eating habits or physical activity routines.

Without an appropriate weight maintenance strategy, patients may struggle to maintain their results once medication is discontinued.

For a more detailed explanation of the underlying mechanism, read What Is GLP-1 and How Does It Work for Weight Management?.

What Does Research Say About Weight Regain After Stopping Semaglutide?

One of the most important studies examining weight regain after GLP-1 discontinuation is the STEP 1 Trial Extension, published in Diabetes Obesity and Metabolism in 2022.

This extension study evaluated 327 participants following the original 68-week treatment period.

Participants receiving semaglutide 2.4 mg had achieved an average weight reduction of 17.3% during treatment.

After semaglutide and structured lifestyle interventions were discontinued, participants were followed for another year.

Hasil STEP 1 Extension

Clinical outcome Average result
Weight reduction during 68 weeks of treatment 17,3%
Weight regained during the following year 11.6 percentage points of initial body weight
Net weight reduction remaining compared with baseline 5,6%

In other words, participants in this study regained approximately two-thirds of the weight they had previously lost during the year following treatment discontinuation.

However, some of the initial weight loss was still maintained.

It is important to understand that these findings represent group averages, not a guaranteed outcome for every patient. The study also discontinued both semaglutide and the structured lifestyle intervention.

Key finding: Discontinuing semaglutide may be followed by substantial weight regain, highlighting the importance of long-term obesity management.

Source: Wilding et al., 2022.

Can Weight Regain Also Occur After Stopping Mounjaro?

Yes. Weight regain has also been observed in clinical research involving tirzepatide, the active ingredient in Mounjaro.

One important study is SURMOUNT-4, published in JAMA in 2024.

The trial evaluated patients who had initially received tirzepatide for 36 weeks.

After this initial treatment period, participants were randomly assigned either to continue tirzepatide or switch to placebo for another 52 weeks.

The results showed:

  • Participants who continued tirzepatide achieved an additional average weight reduction of 5.5%.
  • Participants who switched to placebo experienced an average weight increase of 14.0% from their weight at randomization.

These percentages describe weight changes during the 52-week randomized period, rather than the proportion of previously lost weight regained.

The study suggests that continuing treatment can help maintain weight reduction in appropriately selected patients, while discontinuation may be followed by significant weight regain.

However, decisions about long-term medication use must consider the patient's medical indications, benefits, risks, and tolerability.

For a comparison of these medications, read Wegovy vs Mounjaro for Weight Loss: What’s the Difference?.

Does Everyone Regain Weight After Stopping GLP-1?

Not necessarily.

Although clinical studies show that weight regain is common after discontinuing treatment, individual responses vary.

Some patients may maintain a substantial proportion of their weight loss, while others experience greater weight regain.

Factors that may influence long-term results include:

  • The amount of weight lost during treatment.
  • Changes in appetite after discontinuation.
  • Eating patterns and physical activity.
  • Muscle mass and body composition.
  • Existing metabolic conditions.
  • Current medications.
  • Consistency of follow-up and weight maintenance strategies.

Weight regain should not automatically be interpreted as a personal failure or evidence that the previous treatment was unsuccessful.

Obesity is a chronic condition involving complex biological mechanisms and may require ongoing management in some patients.

How Can You Prevent Weight Regain After Stopping GLP-1?

No strategy can guarantee that weight regain will not occur.

However, several approaches may help patients maintain their weight loss and support long-term metabolic health.

1. Create a Weight Maintenance Plan Before Stopping Treatment

A weight maintenance strategy should ideally be established before medication is discontinued, rather than waiting until weight regain begins.

A physician can evaluate current body weight, realistic goals, metabolic health, eating patterns, and the need for continued monitoring.

2. Maintain Adequate Protein Intake

Preserving muscle mass is an important consideration during and after weight loss.

Adequate protein intake, tailored to the patient's nutritional requirements and medical conditions, can help support muscle maintenance.

Protein requirements vary, particularly in patients with certain health conditions, such as kidney disease.

3. Include Regular Strength Training

Resistance training can help preserve muscle mass during and after weight loss.

It can be combined with aerobic exercise according to the patient's fitness level, physical abilities, and medical circumstances.

4. Follow a Sustainable Eating Plan

Highly restrictive diets may be difficult to maintain over time.

A more practical approach is to develop balanced eating habits with appropriate portions, adequate protein, fiber, and essential nutrients.

The goal is not to maintain extreme calorie restriction but to establish an eating pattern that can be followed consistently.

5. Monitor Weight and Appetite Changes

Regular weight monitoring can help identify changes early.

In addition to body weight, patients may track waist circumference, appetite changes, eating habits, and physical activity.

Monitoring frequency should be individualized and should not create unnecessary stress.

6. Discuss Long-Term Treatment Options with Your Doctor

Some patients may benefit from long-term pharmacological treatment to help maintain the benefits of weight loss.

Depending on the patient's condition, options may include continuing effective therapy, adjusting treatment according to approved prescribing information, considering another treatment, or discontinuing medication with closer monitoring.

These decisions should be individualized.

Patients should not stop, reduce, or restart GLP-1-based medications without consulting their physician.

Do You Need to Take GLP-1 Medication for Life?

There is no single treatment duration that is appropriate for everyone.

However, obesity medications are often used as part of long-term management, particularly when their benefits continue to outweigh potential risks.

Modern clinical guidelines recognize that effective weight management medications may need to be continued after weight loss goals are achieved to help maintain health benefits.

This does not mean that every patient must take GLP-1 medication for life.

A physician should periodically evaluate:

  • Treatment effectiveness.
  • Side effects and tolerability.
  • Changes in medical conditions.
  • Patient preferences and needs.
  • Treatment costs and accessibility.
  • The most appropriate long-term management strategy.

For some patients, discontinuing treatment may be appropriate because of medical circumstances or other considerations. In such cases, an ongoing monitoring and weight maintenance plan remains important.

Can Gradually Reducing GLP-1 Dosage Prevent Weight Regain?

Some patients wonder whether gradually reducing the medication dosage, commonly called tapering, can help prevent weight regain.

Currently, high-quality clinical evidence is insufficient to conclude that tapering is reliably more effective than stopping treatment directly for preventing weight regain.

Therefore, tapering should not be considered a proven strategy for guaranteeing long-term weight stability.

Any dose adjustment should follow approved prescribing information, clinical response, and the treating physician's recommendations.

Patients who have stopped treatment for a period of time should also avoid restarting at their previous dose without medical evaluation, as dose adjustment or re-escalation may be necessary to reduce adverse effects.

What Should You Do If You Have Already Regained Weight?

If your weight begins increasing after stopping GLP-1 medication, the first step is to seek an appropriate evaluation rather than immediately restarting your previous medication dose.

A physician may assess:

  1. How much weight has been regained and over what period.
  2. Whether appetite or eating habits have changed.
  3. Changes in physical activity or muscle mass.
  4. Medical conditions, other medications, or metabolic factors that may contribute.
  5. Whether the patient still meets the indications for medical weight management treatment.

Based on this assessment, the physician can recommend an appropriate approach, including structured lifestyle interventions or medication-based treatment when clinically indicated.

Medical Weight Management vs Body Contouring: Are They the Same?

Medical weight management and body contouring have different purposes.

Medical weight management focuses on overall body weight regulation and metabolic health.

Body contouring treatments, on the other hand, aim to address specific concerns related to body shape, localized fat, or skin firmness, depending on the treatment.

For example, a patient who has achieved a stable body weight may still experience localized fat accumulation around the abdomen, arms, or double chin.

In such cases, a physician may consider body contouring treatments separately, including Fat Loss Therapy, Meso Fat Apoptosis, or Exilis Elite Body Contouring.

However, body contouring treatments are not substitutes for obesity management and have not been shown to prevent weight regain after discontinuing GLP-1 medication.

Weight Maintenance and Medical Weight Management at Ovela Clinic Jakarta

Losing weight is one stage of weight management. Maintaining the results over time is equally important.

Through WeightMod Therapy at Ovela Clinic, patients can consult a physician about medical weight management strategies tailored to their health conditions and individual needs.

A consultation may be helpful for patients who:

  • Are considering GLP-1-based treatment.
  • Have achieved weight loss and want to maintain their results.
  • Are considering discontinuing treatment.
  • Have experienced weight regain after stopping semaglutide or tirzepatide.
  • Need medical evaluation regarding long-term treatment options.

WeightMod emphasizes medical assessment and physician supervision, including metabolic health evaluation, treatment response, medication tolerability, and long-term management planning.

Prescription medications are considered only when clinically appropriate and in accordance with applicable indications.

Frequently Asked Questions About Weight Regain After GLP-1

1. Will I definitely regain weight after stopping GLP-1?

Not necessarily. However, clinical studies show that weight regain is common after discontinuation. The amount of weight regained varies between individuals.

2. How much weight can you regain after stopping Wegovy?

In the STEP 1 extension study, participants regained approximately two-thirds of their previously lost weight on average during the year after semaglutide and structured lifestyle interventions were discontinued. This does not predict the outcome for every patient.

3. Can you regain weight after stopping Mounjaro?

Yes. The SURMOUNT-4 trial found substantial weight regain among participants who discontinued tirzepatide compared with those who continued treatment.

4. Do you need to take GLP-1 medication forever?

Not always. Treatment duration depends on medical indications, response, benefits, risks, and physician evaluation. Some patients may require long-term management.

5. Are diet and exercise enough to maintain weight loss after GLP-1?

Diet and physical activity are essential, but they may not completely prevent weight regain for everyone. Some patients may benefit from ongoing medical support or continued treatment.

6. Should GLP-1 medication be tapered before stopping?

There is currently insufficient strong evidence that tapering reliably prevents weight regain. Any dosage adjustment or discontinuation should be discussed with a physician.

7. Can I restart Wegovy or Mounjaro if I regain weight?

Do not restart medication at your previous dose without medical evaluation. Dosing and titration requirements may change after treatment interruption.

8. Where can I consult a doctor about weight regain after GLP-1 in Jakarta?

Patients can arrange a consultation through WeightMod Therapy at Ovela Clinic Jakarta to evaluate weight regain, overall health, and appropriate medical weight management options.

Conclusion: Losing Weight Matters, but Maintaining It Matters Too

Weight regain can occur after stopping GLP-1-based treatment, but the amount and rate of weight regain vary between individuals.

Clinical research involving semaglutide and tirzepatide demonstrates that discontinuing treatment may be followed by substantial weight regain.

These findings highlight the importance of viewing obesity and weight management as conditions that may require long-term care.

A successful weight management strategy should focus not only on how much weight is lost but also on how those results can be maintained safely and sustainably.

If you are considering stopping GLP-1 medication or have experienced weight regain after treatment, a medical consultation can help determine the most appropriate next steps.

--> Learn more Medical Weight Management with WeightMod Therapy at Ovela Clinic Jakarta.

Ovela Clinic Tebet – South Jakarta

WhatsApp: 0857-8888-9188

Ovela Clinic Kebon Jeruk – West Jakarta

WhatsApp: 0822-4040-8086

Book Your WeightMod Consultation

Medical References

  1. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Obesity and Metabolism. 2022;24:1553–1564. https://doi.org/10.1111/dom.14725
  2. Aronne LJ, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38–48. https://doi.org/10.1001/jama.2023.24945
  3. Pharmacotherapy for Obesity Management in Adults: 2025 Clinical Practice Guideline Update. Canadian Medical Association Journal. https://pmc.ncbi.nlm.nih.gov/articles/PMC12350384/

Medical Disclaimer: This article is intended for educational purposes only and does not replace individualized medical advice. GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists should only be used, adjusted, or discontinued according to medical assessment and applicable prescribing information.

Ready to Consult with Our Experts?

Get a free consultation with our experienced medical team. Contact us via WhatsApp for more information or to book your appointment.

Ovela Clinic Tebet

Ovela Clinic Kebon Jeruk